BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12548421)

  • 1. Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus.
    Taussky D; Rousson V; Pescia R
    Int J Colorectal Dis; 2003 Mar; 18(2):167-71. PubMed ID: 12548421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of an exclusive concomitant radio-chemotherapy treatment in non operable esophageal cancer: results of a 10-year experience in Antoine-Lacassagne Center].
    Magné N; François E; Touati L; Marcy PY; Van Houtte P; Lagrange JL
    Bull Cancer; 2005 Feb; 92(2):184-90. PubMed ID: 15749648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
    Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results of neoadjuvant radiochemotherapy in squamous carcinoma of the thoracic esophagus].
    Pedrazzani C; Laterza E; Pasini F; Grandinetti A; Bernini M; Giacopuzzi S; Zerman G; Tasselli S; Ruzzenente A; De Manzoni G
    Minerva Chir; 2005 Feb; 60(1):11-6. PubMed ID: 15902048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
    Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
    Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
    Delouche D; Haefliger JM
    Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
    Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Narumiya K; Takasaki K; Mitsuhashi M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):803-7. PubMed ID: 12852347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.
    Tahara M; Ohtsu A; Hironaka S; Boku N; Ishikura S; Miyata Y; Ogino T; Yoshida S
    Jpn J Clin Oncol; 2005 Jun; 35(6):316-23. PubMed ID: 15961436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The combined radio-chemotherapy of inoperable esophageal cancer].
    Köhler AH
    Radiobiol Radiother (Berl); 1990; 31(6):497-502. PubMed ID: 1714081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy of inoperable esophageal cancer. Retrospective analysis apropos of 108 cases].
    Geara F; Calais G; Chauvet B; Reynaud-Bougnoux A; Le Floch O
    Bull Cancer Radiother; 1990; 77(1):69-76. PubMed ID: 8703544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
    Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
    Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S;
    Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.